On the other hand, Takenaka et al. found different mutation frequencies in advanced rectal cancer from Brazilian and Argentinian patients in TP53 (78.1% vs. 11%, respectively), KRAS (40.9% vs. 6%) and FBXW7 (17.5% vs. 6%). The gene discussed is TP53; the disease is rectal cancer.